,uCi/ml; 40 Ci/mmol) (both from New England Nuclear).
IgE released a portion of the stored material. Growth studies of subdlones showed that MST cells tolerate a 10-fold variation in glycosaminoglycan content. Incubation of cells with sodium chlorate reduced glycosaminoglycan sulfation by >95% without affecting cell growth. Thus, granule glycosaminoglycans appear to be nonessential for growth of MST cells.
The heparin proteoglycan is unique to connective tissue mast cells (1) . Although much is known about its structure and biosynthesis (2) (3) (4) (5) , the biological role of native heparin has remained elusive. Intravenously administered heparin inhibits blood coagulation through activation of antithrombin III (6) and depresses arterial smooth muscle cell proliferation (7) . When added to cultured cells, heparin activates basic fibroblast growth factor (8, 9) and alters cell adhesion to extracellular matrices composed of type V collagen (10) and fibronectin (11) . Released heparin from mast cells can induce uptake of low density lipoproteins by macrophages (12) . Heparin also inhibits binding of lipoprotein lipase (13) , thrombospondin (14) , and herpes simplex (15) to cell surface heparan sulfate proteoglycans. In mast cells, heparin may play an intracellular role in granule condensation and secretion.
Suitable models for connective tissue mast cells are needed to gain further insight into the function of heparin. Primary mast cells can be obtained from animals, but their numbers are few and their propagation in vitro has proven difficult (16) . To circumvent these problems, Reynolds et al. (17) isolated transformed mast cell lines from bone marrow cultures infected with Kirsten sarcoma virus. In this report, we describe additional cell lines derived from the Furth murine mastocytoma (18) . Unlike other cell culture models, the mastocytoma lines divide rapidly, produce heparin continuously, and permit nutritional and genetic experiments under defined culture conditions. A preliminary account of this work has been presented (19 (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) ,uCi/ml; 40 Ci/mmol) (both from New England Nuclear).
Radioactive GAGs were isolated by anion-exchange chromatography and ethanol precipitation as described by Bame and Esko (20) , except that samples bound to DEAE-Sephacel (Pharmacia LKB) were washed with 0.25 M NaCl in 20 mM sodium acetate (pH 6.0) and eluted with 2.0 M NaCl in acetate buffer. Samples were 3-eliminated with 0.5 M NaOH for 24 h at 40C and reduced with 1 M NaBH4 (21) to remove any covalently linked peptides. Chondroitin sulfate was depolymerized with chondroitinase ABC according to the manufacturer's directions (ICN), and the enzyme was inactivated by boiling.
To measure GAGs chemically, preparations were first treated with 10 units of DNase I and RNase A (Sigma) at 10 ,ug/ml to degrade nucleic acids. The GAGs were repurified by anion-exchange chromatography, and uronic acid was Abbreviations: aManR, anhydromannitol; FBS, fetal bovine serum; GAG, glycosaminoglycan; GlcA, D-glucuronic acid; IdoA, L-iduronic acid; ADi-4S, 2-acetamido-2-deoxy- 1To whom reprint requests should be addressed.
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quantitated by the method of Bitter and Muir (22 (18) , the Furth murine mastocytoma has been maintained by serial passage through (Leaden x A) F1 mice. A tumor cell suspension was generated, and serial passage in spinner culture removed any contaminating macrophages (2) . The cells were then treated with penicillin G (100 units/ml), streptomycin sulfate (100 ,ug/ml), Fungizone (2.5 ,ug/ml; GIBCO), gentamycin sulfate (50 t&g/ml), and tetracycline (10 pug/ml) to ensure that they were devoid of bacterial and fungal contamination. This cell suspension was designated MST and frozen in liquid nitrogen using a programmed temperature gradient (Cryomed, Mt. Clemens, MI). Greater (Fig. 2) . Treatment (Fig. 2) and by paper chromatography (data not shown). When the 35S cpm recovered in disaccharides were corrected for the number of sulfate groups present, ADi-4S and ADi-diSE constituted about 75% and 25% of the 35S5 labeled disaccharides, respectively. rH]GAGs were treated with HNO2 at pH 1.5, which cleaves heparin and heparan sulfate at N-sulfted GlcN residues (27) . Gel-filtration chromatography showed that 20% of the 3H-labeled material eluted in the Vo fraction ofthe column and was susceptible to chondroitinase ABC (data not shown), Proc. Natl. Acad Sci. USA 89 (1992) (Figs. 1 and 2 ). The remainder eluted in the position ofdisaccharides and tetrasaccharides. Calculation of the areas under these peaks indicated that 80-85% of the GlcN residues were N-sulfated (20) . Further analysis of the disaccharide fraction obtained from MST heparin showed that its composition was similar to that of commercial heparin, whereas it differed considerably from that of heparan sulfate produced by CHO cells (Fig. 3) . The di-O-sulfated disaccharide, IdoA (2-OSO3)-aManR (6-OS03) (IdoA = L-iduronic acid and aManR = anhydromannitol), was the predominant product obtained on deamination of either MST or commercial heparin, whereas all mono-Osulfated disaccharides occurred in smaller amounts. Small quantities of nonsulfated disaccharides were also present. Lesser amounts of disaccharides with 3-0-sulfated aManR units were generated on deamination of MST heparin compared to commercial heparin (1.3% vs. 3.1%, respectively). Intact GAG chains from MST cells did not exhibit high affinity for antithrombin (data not shown), indicating that the 3-0-sulfated GlcN residues apparently do not lie within the recognition sequence required for high-affinity binding (31 MST subclones varied considerably in GAG content (Fig.  1) , suggesting that the cells could tolerate lower amounts of intracellular polysaccharide. Variations of 6-to 10-fold were seen in labeling studies among the MST subclones, yet the proportion of heparin and chondroitin sulfate E remained constant (Fig. 1 (27) .
Oligosaccharides derived from the cleavage of commercial heparin were radiolabeled by reduction of reducing terminal aMan units with NaB3H4 (28) , and oligosaccharides from MST [3H]heparin were reduced using NaBH4. HNO2 treatment of MST heparin and commercial heparin yielded -701% disaccharides.
[3H]Heparan sulfate from CHO cells was completely depolymerized by hydrazinolysis (29) and sequential treatments with HNO2 at pH 1.5 (cleavage at N-sulfated GlcN residues) and pH 3.9 (cleavage at free GlcN residues) (30) . The resulting oligosaccharides, -70%o of which were disaccharides, were reduced with NaBH4. Disaccharides in all preparations were isolated by G-50 chromatography and fractionated by strong anion-exchange HPLC (28) . The total 3H cpm recovered in sulfated disaccharides was set equal to 100%6. Nonsulf, nonsulfated disaccharides, GlcA-aManR (GIcA = D-glucuronic acid) and IdoAaManR; GSM, GlcA (2-OSO3)-aManR; GMS, GlcA-aManR (6-OS03);
IMS, IdoA-aManR (6-OS03); ISM, IdoA (2-OSO3)-aManR; GM3S, GlcA-aManR (3-OS03); ISMS, IdoA (2-OS03)-aManR (6-OS03); GM3,6S, GlcA-aManR (3,6-di-OS03). inhibitor ofmacromolecular sulfation (33) , reduced the extent of sulfation of mixed GAGs by over 40-fold, as measured by the ratio of 35QS4 and [3HIGlcN incorporation (Fig. 5 Inset) . Assembly of the polysaccharide backbone was not affected since the amount of [3HJGAG only declined modestly at the highest concentration tested (30 mM). The dramatic reduction in GAG sulfation also did not result in altered cell growth (Fig. 5 ) or morphology (data not shown).
DISCUSSION
MST and MST-A1 cells display many traits typical of connective tissue mast cells, most notably the production of heparin. The distinguishing structural features of this polysaccharide include a high overall sulfate content, as demonstrated by the retarded elution position on anion-exchange chromatography (Fig. 2) , a GlcNSO3/(AGcNAc + GlcNSO3) ratio of 20.8, and a preponderance of the di-O-sulfated disaccharide, -IdoA (2-0S03)-GlcNSO3 (6-OS03)-, over any mono-O-sulfated disaccharide unit (Fig. 3) . The apparent lack of heparin chains with high affinity for antithrombin is intriguing, considering that previous experiments using heterogeneous (and presumably impure) cell preparations derived from the same tumor tissue yielded high-affinity heparin molecules that accounted for 20o ofthe total polysaccharide to as much as 50% after treating cells with butyrate (25) . These discrepancies underscore more recent observations that point to complex regulatory mechanisms in the formation of the antithrombin-binding region (34 (Fig. 4) poly(L-lysine), suggesting that the adhesion mechanism is somewhat selective.
MST and MST-A1 provide additional models for studying the function of GAGs in secretory cells. As shown in Fig. 1 , stable subclones from MST exhibited up to 10-fold differences in GAG content. MST and MST-A1 cells also tolerate a 40-fold reduction of GAG sulfation with no effect on cell viability or growth. Further studies are needed to determine whether alterations in GAG content and sulfation perturb other cellular functions, such as granule stability, regulated secretion, or general packaging of granules. As reported recently by Krilis et al. (39) , undersulfated GAGs in mast-like cells may be associated with continuous release of granular components. By using the cell culture system described in this report, heparin production can now be manipulated chemically, genetically, and nutritionally to explore these questions.
